INCOME STATEMENT
Par Drugs & Chemicals Ltd.
NSE
Apr 30
99.41
-2.73 ( -2.67%)
Volume
4921
Prev. Close
102.14
Open Price
101.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE04LG01015
|
Market Cap. ( ₹ in Cr. )
|
122.32
|
P/BV
|
1.26
|
Book Value ( ₹ )
|
78.64
|
BSE Code
|
-
|
52 Week High/Low ( ₹ )
|
348/81
|
FV/ML
|
10/1
|
P/E(X)
|
8.44
|
NSE Code
|
PARBE
|
Book Closure
|
21/09/2024
|
EPS ( ₹ )
|
11.78
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Gross] | 106.73 | 107.66 | 83.98 | 68.19 | 62.78 |
Less: Excise/Sevice Tax/Other Levies | 11.62 | 12.57 | 9.78 | 8.32 | 7.69 |
Revenue From Operations [Net] | 95.11 | 95.10 | 74.20 | 59.88 | 55.09 |
Other Operating Revenues | 0.53 | 0.65 | 0.87 | 0.87 | 0.76 |
Total Operating Revenues | 95.64 | 95.75 | 75.07 | 60.75 | 55.85 |
| | | | | |
Other Income | 0.24 | 0.24 | 0.18 | 0.19 | 0.10 |
Total Revenue | 95.88 | 95.99 | 75.26 | 60.94 | 55.95 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 33.32 | 41.03 | 29.61 | 22.09 | 22.19 |
Operating And Direct Expenses | 25.09 | 26.08 | 21.04 | 15.56 | 15.97 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 0.47 | -0.70 | -0.79 | -0.21 | 1.46 |
Employee Benefit Expenses | 5.50 | 4.89 | 4.10 | 3.98 | 4.11 |
Finance Costs | 0.11 | 0.13 | 0.45 | 0.64 | 0.79 |
Depreciation And Amortisation Expenses | 3.44 | 3.23 | 3.28 | 2.82 | 2.76 |
Other Expenses | 8.44 | 6.25 | 4.85 | 3.32 | 2.66 |
Total Expenses | 76.37 | 80.91 | 62.56 | 48.20 | 49.96 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 19.52 | 15.08 | 12.70 | 12.74 | 5.99 |
| | | | | |
Profit/Loss Before Tax | 19.52 | 15.08 | 12.70 | 12.74 | 5.99 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 4.98 | 3.80 | 3.35 | 3.36 | 1.00 |
Deferred Tax | 0.04 | -0.05 | 0.14 | -0.25 | 0.23 |
Total Tax Expenses | 5.02 | 3.75 | 3.49 | 3.11 | 1.23 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 14.50 | 11.33 | 9.21 | 9.63 | 4.76 |
| | | | | |
Extraordinary Items | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 |
Profit/Loss From Continuing Operations | 14.50 | 11.33 | 9.21 | 11.61 | 4.76 |
| | | | | |
Profit/Loss For The Period | 14.50 | 11.33 | 9.21 | 11.61 | 4.76 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 |
Diluted EPS (Rs.) | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 0.00 | 1.54 | 0.00 | 1.54 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 |
Equity Dividend Rate (%) | 0.00 | 0.00 | 12.50 | 0.00 | 12.50 |